HomeLXEO • NASDAQ
add
Lexeo Therapeutics Inc
Previous close
$8.32
Day range
$8.30 - $8.72
Year range
$1.45 - $10.38
Market cap
632.07M USD
Avg Volume
1.29M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.95M | -26.69% |
Net income | -20.28M | 31.22% |
Net profit margin | — | — |
Earnings per share | -0.33 | 62.92% |
EBITDA | -21.50M | 31.50% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 122.76M | -21.82% |
Total assets | 143.84M | -17.27% |
Total liabilities | 23.01M | -33.37% |
Total equity | 120.83M | — |
Shares outstanding | 72.99M | — |
Price to book | 3.78 | — |
Return on assets | -33.83% | — |
Return on capital | -39.16% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -20.28M | 31.22% |
Cash from operations | -29.55M | -65.94% |
Cash from investing | 35.01M | 42,281.93% |
Cash from financing | 52.00K | 172.22% |
Net change in cash | 5.52M | 130.71% |
Free cash flow | -22.89M | -191.21% |
About
Founded
2017
Website
Employees
61
